Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMVT
IMVT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMVT News
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
US Stocks Plummet as Oil Prices Surge
Apr 02 2026
NASDAQ.COM
Immunovant Reports Disappointing Trial Results, Shares Drop
Apr 02 2026
stocktwits
Immunovant's Phase 3 Trials Fail to Meet Primary Endpoints
Apr 02 2026
NASDAQ.COM
Immunovant Shares Drop 10% After Batoclimab Trial Failure
Apr 02 2026
seekingalpha
Logos Increases Immunovant Stake to $35 Million
Mar 15 2026
NASDAQ.COM
Logos Global Management Increases Immunovant Stake to 1.375 Million Shares
Mar 15 2026
Fool
S&P 500 Futures Rise in Pre-Market Session; Adobe and Ulta Beauty Underperform
Mar 13 2026
Barron's
Alpine Global Management Reduces Immunovant Holdings
Mar 11 2026
Fool
S&P 500 Futures Rise in Pre-Market Trading; Circle Internet Group and Axon Enterprise Take the Lead
Feb 25 2026
Barron's
Purcell & Lefkowitz Investigates Immunovant for Potential Fiduciary Breaches
Feb 17 2026
PRnewswire
Immunovant Q3 Earnings Beat Expectations with Strong Cash Position
Feb 06 2026
seekingalpha
Purcell & Lefkowitz Investigates Immunovant's Board Actions for Shareholder Breach
Jan 05 2026
PRnewswire
IMVT Options Trading Kicks Off in February 2026
Dec 19 2025
NASDAQ.COM
Should You Consider Buying Immunovant Stock Following Roivant Sciences' $350 Million Stake Increase?
Dec 18 2025
NASDAQ.COM
Immunovant (IMVT) Rises 14.0% Following $550 Million Equity Raise Backed by Roivant for IMVT-1402 - Is the Bullish Outlook Still Valid?
Dec 15 2025
Yahoo Finance
Show More News
